Silencing PBX3 in glioma cells has been shown to reduce proliferation both in vitro and in vivo [54], and targeting of PBX3 by miR-98 reduced invasion and migration of glioma cells in an orthotopic model [18]. The gene discussed is PBX3; the disease is central nervous system cancer.